2024
For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]
Mason-Otey A, Lundsberg L, Culhane J, Merriam A. For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]. Obstetrics And Gynecology 2024, 143: 46s-46s. DOI: 10.1097/01.aog.0001013576.14925.24.Peer-Reviewed Original ResearchInduction of laborBody mass indexBody mass index categoriesDose of misoprostolMisoprostol doseClass IIIMass indexProlonged induction of laborClass IIAssociated with increased BMIClass IIncreased BMIPre-gestational diabetesClass II obesityClass I obesityRetrospective cohort analysisMisoprostol administrationObese patientsII obesityMisoprostolInvestigate safetyHigh dosesPrimary outcomeCohort analysisPatients
2023
Maternal Morbidity Risk Factors in Nulliparas
Merriam A, Metz T, Allshouse A, Silver R, Haas D, Grobman W, Simhan H, Wapner R, Wing D, Mercer B, Parry S, Reddy U, Investigators +. Maternal Morbidity Risk Factors in Nulliparas. American Journal Of Perinatology 2023, 41: e1878-e1884. PMID: 37150178, DOI: 10.1055/a-2088-2586.Peer-Reviewed Original ResearchVenous thromboembolic eventsSelf-identified black raceComposite maternal morbidityPrimary maternal outcomeSevere maternal morbidityMaternal morbidityChronic kidney diseaseBlack raceRisk factorsChronic hypertensionHypertensive disordersMaternal outcomesPregestational diabetesKidney diseaseMedical conditionsMulticenter prospective observational cohortPrepregnancy body mass indexPreexisting medical comorbiditiesPrior obstetric historyProspective observational cohortMorbidity risk factorsBody mass indexMultiple risk factorsDays of deliveryLog-binomial regression